References
Blomhoff S, Haug TT, Hellstrom K, et al.: Randomized controlled general practice trial of sertraline, exposure therapy and combined treatment in generalized social phobia. Br J Psychiatry 2001, 179:23–30.
Research Unit on Pediatric Psychopharmacology Anxiety Study Group: Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001, 344:1279–1285.
Bonnet U: Moclobemide: therapeutic use and clinical studies. CNS Drug Rev 2003, 9:97–140.
Van Ameringen MA, Lane RM, Walker JR, et al.: Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry 2001, 158:275–281.
Stein DJ, Stein MB, Pitts CD, et al.: Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo controlled paroxetine trials. J Clin Psychiatry 2002, 63:152–155.
Allgulander C, Nilsson B: A prospective study of 86 new patients with social anxiety disorder. Acta Psychiatr Scand 2001, 103:447–452.
Rights and permissions
About this article
Cite this article
Hollander, E., Samons, D.M. Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomized controlled trial. Curr Psychiatry Rep 5, 249–251 (2003). https://doi.org/10.1007/s11920-003-0053-x
Issue Date:
DOI: https://doi.org/10.1007/s11920-003-0053-x